Michelle Robertson's Net Worth

$1.32 Million

Estimate Recalculated Jul 11, 2024 06:02AM EST

Who is Michelle Robertson?

Michelle Robertson has an estimated net worth of $1.32 Million. This is based on reported shares across multiple companies, which include Editas Medicine, Inc., Verastem, Inc., MOMENTA PHARMACEUTICALS INC, and GERON CORP.

SEC CIK

Michelle Robertson's CIK is 0001755098

Past Insider Trading and Trends

2021 was Michelle Robertson's most active year for acquiring shares with 6 total transactions. Michelle Robertson's most active month to acquire stocks was the month of January. 2019 was Michelle Robertson's most active year for disposing of shares, totalling 7 transactions. Michelle Robertson's most active month to dispose stocks was the month of January. 2021 saw Michelle Robertson paying a total of $153,250.00 for 115,464 shares, this is the most they've acquired in one year. In 2021 Michelle Robertson cashed out on 11,568 shares for a total of $397,727.36, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Editas Medicine, Inc. (EDIT) Snapshot price: $7.155

EVP, CHIEF FINANCIAL OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-0.88%
-949.00
$9.87
-$9,368.53
106.61K
May 11
Form 4
+41.07%
31.32K
$8.89
-$1,635.76
107.56K
Mar 2 - Mar 3
Form 4
-5.32%
-4.29K
$9.67
-$41,435.14
76.24K
Feb 13
Form 4
-2.13%
-1.75K
$8.16
-$14,296.50
80.53K
Jan 10
Form 4
-0.23%
-193.00
$10.23
-$1,974.39
82.28K
Dec 5
Form 4
-0.23%
-192.00
$15.01
-$2,881.92
82.47K
Sep 6
Form 4
-1.81%
-1.53K
$11.54
-$17,616.85
82.67K
Jun 3
Form 4
-0.90%
-767.00
$17.33
-$13,290.35
84.19K
Mar 3
Form 4
+170.04%
53.5K
—
—
84.96K
Feb 10
Form 4
-5.25%
-1.74K
$25.70
-$44,820.80
31.46K
Jan 11
Form 4
+15.56%
4.47K
—
—
33.21K
Dec 22
Form 4
—
0
$45.33
-$73,375.00
28.73K
Scheduled
Aug 9
Form 4
—
0
$40.33
-$48,375.00
28.73K
Scheduled
Jun 28
Form 4
+55.90%
10.3K
—
—
28.73K
Mar 2
Form 4
-7.84%
-1.57K
$78.27
-$122,727.36
18.43K
Jan 12
Form 4
∞
20K
—
—
20K
Jan 9
Form 3
—
0
—
—
0
No matching records found

Verastem, Inc. (VSTM) Snapshot price: $13.43

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
8.33K
—
—
8.33K
Jun 18
Form 4
—
0
—
—
0
Mar 11
Form 4
—
0
—
—
0
May 15
Form 4/A
—
0
—
—
0
May 12
Form 4
—
0
—
—
0
Jun 22
Form 4
—
0
—
—
0
Nov 15
Form 3
—
0
—
—
0
No matching records found

MOMENTA PHARMACEUTICALS INC No price found

Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-49.96%
-6.80K
$15.00
-$102,030.00
6.81K
Scheduled
Oct 25
Form 4
+100.19%
6.81K
$13.83
-$40,604.88
13.62K
Scheduled
Oct 17 - Oct 18
Form 4
-40.99%
-4.72K
—
—
6.8K
Apr 13
Form 4
-5.75%
-703.00
$13.10
-$9,209.30
11.53K
Scheduled
Feb 14
Form 4
+39.46%
3.46K
$12.70
-$17,907.00
12.23K
Scheduled
Feb 12 - Feb 13
Form 4
—
0
—
—
0
Feb 11
Form 4
—
0
—
—
0
Oct 17
Form 3
—
0
—
—
0
No matching records found

GERON CORP (GERN) Snapshot price: $1.905

EVP, Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 6
Form 4
—
0
—
—
0
Feb 14
Form 4
—
0
—
—
0
Sep 25
Form 3
—
0
—
—
0
No matching records found